Natalia Ramírez

Natalia Ramírez

Auto-generated profile, based on publicly available information

Natalia Ramírez

Oncohematology Research Group, Navarrabiomed-Miguel Servet Foundation, Pamplona, Spain

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
EBEVA BANDRES
EVA BANDRES
ECE Cubedo
E Cubedo
XAXabier Agirre
Xabier Agirre
RMR Malumbres
R Malumbres
RZRuth Zarate
Ruth Zarate
Jesus Garcia-FoncillasJesus Garcia-Foncillas
Jesus Garcia-Foncillas
MicroRNAs (miRNAs) are short non-coding RNA molecules playing regulatory roles by repressing translation or cleaving RNA transcripts. Although the number of verified human miRNA is still expanding, only few have been functionally described. However, emerging evidences suggest the potential involvement of altered regulation of miRNA in pathogenesis of cancers and these genes are thought to function as both tumours suppressor and oncogenes.

11 June 2009 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
EBEVA BANDRES
EVA BANDRES
XAXabier Agirre
Xabier Agirre
NBNerea Bitarte
Nerea Bitarte
NRNatalia Ramirez
Natalia Ramirez
RZRuth Zarate
Ruth Zarate
Jesus Garcia-FoncillasJesus Garcia-Foncillas
Jesus Garcia-Foncillas
In the last years, microRNAs (miRNA) have emerged as new molecular players involved in carcinogenesis. Deregulation of miRNAs expression has been shown in different human cancer but the molecular mechanism underlying the alteration of miRNA expression is unknown. To identify tumor‐supressor miRNAs silenced through aberrant epigenetic events in colorectal cancer (CRC), we used a sequential approach. We first identified 5 miRNAs down‐regulated in patient with colorectal cancer samples and located around/on a CpG island. Treatment with a DNA methyltransferase inhibitor and a HDAC inhibitor restored expression of 3 of the 5 microRNAs (hsa‐miR‐9, hsa‐miR‐129 and hsa‐miR‐137) in 3 CRC cell lines. Expression of hsa‐miR‐9 was inversely correlated with methylation of their promoter regions as measure by MSP and bisulphate sequencing. Further, methylation of the hsa‐miR‐9‐1, hsa‐miR‐129‐2 and hsa‐miR‐137 CpG islands were frequently observed in CRC cell lines and in primary CRC tumors, but not in normal colonic mucosa. Finally, methylation of hsa‐miR‐9‐1 was associated with the presence of lymph node metastasis. In summary, our results aid in the understanding of miRNA gene regulation showing that aberrant DNA methylation and histone modifications work together to induce silencing of miRNAs in CRC. © 2009 UICC

1 April 2009 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
EBEVA BANDRES
EVA BANDRES
NBNerea Bitarte
Nerea Bitarte
FAFernando Arias
Fernando Arias
JAJackeline Agorreta
Jackeline Agorreta
Puri FortesPuri Fortes
Puri Fortes
Jesus Garcia-FoncillasJesus Garcia-Foncillas
Jesus Garcia-Foncillas
Purpose: microRNAs (miRNA) are small RNAs that function as post-transcriptional regulators of gene expression. Recent evidence has shown that some miRNAs can act as oncogenes or tumor suppressors. This study was conducted to evaluate the potential association of miRNA expression with clinical outcome in patients with gastric cancer.

1 May 2007 in DNA and Cell Biology
Verified
Journal Article
Closed access
EBEVA BANDRES
EVA BANDRES
XAXabier Agirre
Xabier Agirre
NRNatalia Ramirez
Natalia Ramirez
RZRuth Zarate
Ruth Zarate
JGJesus Garcia-Foncillas
Jesus Garcia-Foncillas
MicroRNAs (miRNAs) are nonprotein-coding RNAs that function as posttranscriptional gene regulators. They can regulate their targets directly by mRNA cleavage or by repressing their translation, depending on the degree of complementariety between the miRNA and the target. Recent evidences have shown that miRNA control cell growth, apoptosis, and differentiation. Moreover, miRNA expression correlates with cancers and could have a crucial function in tumor progression. Bioinformatic data indicates that each miRNA can control hundreds of target genes, but identification of the accurate miRNA targets will be crucial to exploit the emerging knowledge of miRNA contribution to cancer process. While the miRNA field is still emerging, the benefit of our understanding of miRNA in cancer is potentially enormous, especially if we are able to apply this knowledge to provide new therapies for patients.

9 March 2010 in British Journal of Cancer
Verified
Journal Article
Open access
RZRuth Zarate
Ruth Zarate
JRJ Rodríguez
J Rodríguez
EBEVA BANDRES
EVA BANDRES
APAna Patiño-García
Ana Patiño-García
MPMariano Ponz-Sarvisé
Mariano Ponz-Sarvisé
JGJ Gacía-Foncillas
J Gacía-Foncillas
Background: Methods: Results: Conclusion:

1 December 2014 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
AVA. Viúdez
A. Viúdez
NRN. Ramírez
N. Ramírez
IHI. Hernández-García
I. Hernández-García
FCF.L. Carvalho
F.L. Carvalho
RVR. Vera
R. Vera
MHM. Hidalgo
M. Hidalgo